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Abstract Several recent studies suggested a role for
neuronal major histocompatibility complex class I (MHCI)
molecules in certain forms of synaptic plasticity in the
hippocampus of rodents. Here, we report for the ﬁrst time
on the expression pattern and functional properties of
MHCI molecules in the hippocampus of a nonhuman pri-
mate, the common marmoset monkey (Callithrix jacchus).
We detected a presynaptic, mossy ﬁber-speciﬁc localiza-
tion of MHCI proteins within the marmoset hippocampus.
MHCI molecules were present in the large, VGlut1-posi-
tive, mossy ﬁber terminals, which provide input to CA3
pyramidal neurons. Furthermore, whole-cell recordings of
CA3 pyramidal neurons in acute hippocampal slices of the
common marmoset demonstrated that application of anti-
bodies which speciﬁcally block MHCI proteins caused a
signiﬁcant decrease in the frequency, and a transient
increase in the amplitude, of spontaneous excitatory post-
synaptic currents (sEPSCs) in CA3 pyramidal neurons.
These ﬁndings add to previous studies on neuronal MHCI
molecules by describing their expression and localization
in the primate hippocampus and by implicating them in
plasticity-related processes at the mossy ﬁber–CA3 syn-
apses. In addition, our results suggest signiﬁcant interspe-
cies differences in the localization of neuronal MHCI
molecules in the hippocampus of mice and marmosets, as
well as in their potential function in these species.
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Introduction
Major histocompatibility complex class I (MHCI) mole-
cules belong to a large and extremely polymorphic family
of cell-surface receptors involved in innate and adap-
tive immune responses in vertebrates (Solheim 1999).
Typical MHCI molecules are heterotrimers composed of
a transmembrane heavy chain, a noncovalently attached
b-2-microglobulin subunit, and a short peptide comprising
8–15 amino acids that is derived from self or foreign
antigens and is presented to cytotoxic T lymphocytes
(Solheim 1999; Cresswell et al. 2005). Although virtually
all nucleated cells express MHCI molecules, their expres-
sion in neurons has remained debatable, as the central
nervous system (CNS) is considered immunologically
silent (Aarli 1983). However, recent data from rodents
demonstrate that MHCI molecules are expressed on the
neurons of the CNS and are involved in the modulation of
certain plasticity processes in the developing and adult brain
(Corriveau et al. 1998; Huh et al. 2000; Goddard et al. 2007;
McConnell et al. 2009). MHCI proteins localize to post-
synaptic sites in the mouse hippocampus, and hippocampal
neurons of MHCI-deﬁcient mice display abnormalities in
synapse structure and in basal synaptic transmission
(Goddard et al. 2007). MHCI genes are well conserved in
mammals; however, there are a number of differences in the
organization, structure, and function of these genes between
rodents and primates (Kumanovics et al. 2003). Our group
has previously demonstrated the expression of certain
MHCI genes in the brain of the adult marmoset monkey;
their expression patterns in this species appeared compa-
rable to the ones observed in rodents (Ro ¨lleke et al. 2006).
Here, we describe the expression pattern of a subset of
MHCI molecules localized exclusively on the presynaptic
side of mossy ﬁber–CA3 synapses in the marmoset hippo-
campus. Furthermore, we investigated the properties of
excitatory synaptic transmission in acute hippocampal
slices of the marmoset monkey and we found that appli-
cation of antibodies against MHCI interfered with synaptic
transmission. The results obtained in this study conﬁrm the
emerging role of MHCI molecules in neuronal plasticity
and indicate interspecies differences in the expression
patterns and functional properties of these proteins in the
hippocampus.
Materials and Methods
Animals
Fifteen common marmoset monkeys (Callithrix jacchus,
14 males and 1 female) were obtained from the breeding
colony at the German Primate Center, Go ¨ttingen, Germany.
All animal experiments were conducted in accordance with
the European Communities Council Directive of Novem-
ber 24, 1986 (86/EEC) and with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals,
and were approved by the Lower Saxony Federal State
Ofﬁce for Consumer Protection and Food Safety. We
investigated healthy, 1 day to 6 years old animals which
were also used for other ongoing studies. For expression
studies, brain sections were from male animals ranging in
age from 1 day old to 6 years old (kindly provided in part
by Dr. B. Cze ´h). Slices for electrophysiology were from 2-,
4-, and 5-year old animals. In all cases, we used the min-
imum number of animals required to obtain consistent data.
Anti-MHCI Antibodies
For the detection of MHCI proteins, monoclonal HCA2
and HC10 antibodies were used (Stam et al. 1986, 1990).
These antibodies react with polymorphic determinants of
classical and some non-classical human MHCI molecules
located in the extracellular alpha-1 domain (Stam et al.
1986, 1990; Seitz et al. 1998; Gauster et al. 2007). The
antibodies were puriﬁed from HCA2 and HC10 hybridoma
supernatants (kindly provided by B. Uchanska-Ziegler) via
ammonium sulfate precipitation followed by puriﬁcation
using Protein G Sepharose (GE Healthcare, Munich, Ger-
many) according to the manufacturer’s instructions. Anti-
bodies were later dialyzed with Amicon concentrators
(Milipore, Billerica, MA, USA) against sterile 0.1 M
phosphate-buffered saline (PBS; pH 7.2) and adjusted to
concentrations of 2 and 1.5 mg/ml, respectively.
Brain Sections
For immunohistochemistry, marmosets were terminally
anesthetized with an overdose of ketamine (50 mg/ml),
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123xylazine (10 mg/ml), and atropine (0.1 mg/ml)]. Animals
were then perfused transcardially with 0.9% saline, fol-
lowed by 200 ml of ﬁxative containing 4% paraformalde-
hyde in 0.1 M sodium phosphate buffer (pH 7.2) for
15 min. The heads were postﬁxed using the same ﬁxative
and the brains were carefully removed from the skulls one
day later. After cryoprotection in 0.1 M PBS (pH 7.2)
containing 30% sucrose, serial coronal sections (40 lm)
were prepared using a cryostat.
Immunocytochemistry for Light Microscopy
Coronal cryosections (40 lm) were collected from mar-
moset brains containing the hippocampal formation,
washed brieﬂy in PBS and quenched of endogenous per-
oxidase activity by 30 min incubation at room temperature
(RT) in 0.5% H202 in distilled water. Sections were rinsed
in PBS, blocked for 1 h at RT [3% normal horse serum and
0.03% Triton-X-100 (Sigma) in PBS], incubated 16 h at
4C with either monoclonal HCA2 IgG (1 mg/ml, 1:500
dilution in 3% normal horse serum and 0.03% Triton-X-
100, in PBS) or with control mouse IgG (Sigma), and
washed again. Sections were then incubated with biotin-
ylated horse anti-mouse IgG (Vector Laboratories, Bur-
lingame, CA, USA; 1:200 dilution in 3% normal horse
serum and 0.03% Triton-X-100, in PBS) for 1 h at RT.
After washing, sections were incubated with avidin–biotin–
horseradish peroxidase (Vectastain Elite ABC Kit, Vector
Laboratories; 1:100 dilution in 3% normal horse serum and
0.03% Triton-X-100, in PBS) for 1 h at RT, washed in PBS
and then again in 0.05 M Tris/HCl (pH 7.2) prior to DAB
detection (DAB detection with or without nickel
enhancement was performed according to the manufac-
turer’s instructions; DAB-Kit, Vector Laboratories). For
immunocytochemistry with HC10 antibody, the epitope
retrieval step was perfomed prior to all other steps by
incubating the sections for 20 min in 10 mM sodium cit-
rate buffer preheated to 80C. Sections were later brought
to room temperature, washed in PBS and quenched of
endogenous peroxidase activity, followed by blocking and
incubation in monoclonal HC10 IgG (1 mg/ml, 1:500
dilution in 3% normal horse serum in PBS). All further
steps were performed as described above with omission of
Triton-X-100 in all the steps. Sections were washed in
0.05 M Tris/HCl (pH 7.6) and again in 0.1 M PBS prior to
xylol clearance, dehydration, and coverslipping with Eukitt
mounting medium (Kindler, Freiburg, Germany). For
Timm’s stain (according to Seress et al. 2001), hippo-
campal slices (1 mm) were immersed in 0.4% Na2S for
30 min, and then ﬁxed for 16 h in 1% paraformaldehyde
and 1.25% glutaraldehyde. The ﬁxed slices were cryopro-
tected, frozen, and cut into 30-lm sections which were
mounted and dried. Sections were then immersed in
developer consisting of 30 ml gum Arabic (50%), 5 ml
citrate buffer (2 M, pH 3.7), 15 ml hydroquinone (5.67%),
and 0.25 ml AgNO3 (17%) for at least 60 min. Digital
images of immunostained tissue sections were acquired
using the Axiophot II microscope (Zeiss). Final images
were assembled in Corel PHOTO-PAINT X3 and are a
composition of 4–6 images encompassing the entire hip-
pocampal formation.
Immunoﬂuorescence and Confocal Microscopy
Antibodies used in double-labeling experiments were
applied sequentially and blocking steps were performed
using normal serum of host species from which respective
secondary antibodies were derived. Cryostat sections
(40 lm) of marmoset brains containing the hippocampal
formation were rinsed in PBS. Non-speciﬁc antibody
binding sites were blocked with 3% normal serum and
0.03% Triton-X-100 (Sigma) in PBS for 1 h at room
temperature. Primary antibodies were used at following
dilutions (diluted in 3% normal serum and 0.03% Triton-X-
100, in PBS): monoclonal mouse HCA2, 1:500; control
mouse IgG 1:500 (Sigma); rabbit anti-PSD95 (Cell Sig-
naling Technology, Danvers, MA, USA), 1:200; rabbit
anti-Piccolo, 1:200; rabbit anti-VGlut1, 1:1,000; rabbit
anti-VGlut2, 1:200; rabbit anti VGAT, 1:200; rabbit anti-
GFAP, 1:200 (all from Synaptic Systems, Go ¨ttingen,
Germany); rabbit anti-calbindin, 1:200 and sheep anti-TH,
1:200 (both from Chemicon International Ltd., Hampshire,
UK). Secondary antibodies (Alexa 488-coupled donkey
anti mouse, Alexa 568-coupled goat anti-rabbit and Alexa
594-coupled donkey anti-sheep, Molecular Probes, Invit-
rogen, Leiden, Netherlands) were used at 1:500 dilution
(diluted in 3% normal serum and 0.03% Triton-X-100, in
PBS). After the antibody incubation steps, sections were
washed in PBS and ﬂoated/mounted on Histobond slides in
distilled water, allowed to dry overnight at 4C and cov-
erslipped with mounting medium (Aqua-Polymount,
Polysciences Inc., Warrington, PA, USA).
Confocal microscopy was performed using a laser-
scanning microscope (LSM 5 PASCAL, Zeiss) with argon
(488 nm) and helium/neon (543 nm) lasers. Confocal
analysis was performed in multiple-tracking mode to avoid
bleed through between channels. High magniﬁcation ima-
ges were obtained as z-series stacks of a region containing
mossy ﬁber terminals at a resolution of 2,048 9 2,048
using an Apochromat 63 9 oil objective (NA = 1.4) and
immersion oil (Immersol, Zeiss; refractive index = 1.518).
The 543 nm laser was always used with a smaller detection
pinhole diameter than the 488 nm laser to produce optical
sections of comparable thickness for colocalization analy-
sis. For substantia nigra, images were taken from single
plane at a resolution of 1,024 9 1,024 using an
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sion oil (Immersol, Zeiss; refractive index = 1.518). For
quantiﬁcation of colocalization signals, intensity correla-
tion coefﬁcients (ICQ, Li et al. 2004) were obtained using
the ImageJ colocalization plug-in (Abramoff et al. 2004)
for a minimum of three images per animal. These values
were compared between the two groups using the Student’s
t-test (GraphPad Prism version 4 for Windows, San Diego,
CA, USA). The region of interest (ROI) was deﬁned using
the green channel (MHCI signal).
PCR Cloning of MHC Class I Transcripts
Isolation of the common marmoset MHC class I cDNA
sequence was carried out by reverse transcriptase poly-
merase chain reaction (RT-PCR). 1 lg of total brain RNA
was reverse transcribed using oligo-d(T) primer (GAC-
TCGAGTCGACATCGA(T)17) and 400 U of reverse
transcriptase (Promega, Mannheim, Germany). An aliquot
of this reaction was used as template in a PCR containing
the primers. The primers were designed using Primer3
program (Rozen and Skaletsky 2000) and were intended to
amplify full length marmoset MHC class I transcripts.
Primer sequences were carrying BamHI restriction sites
and were as follows: forward 50-CACGGATCCCACTT-
TACAAGCCGTGAGAGAC-30, reverse 50-CACGGATCC
CTCCTGTTGCTCTCGGGGGCCTTG-30. Caja-G*1 (Ac-
cesion number: U59637) was obtained and cloned in
pEXPR-IBA103 (IBA Technologies, Go ¨ttingen, Germany).
Protein Extraction and Immunoblot Analysis
Brains were immediately removed from terminally anes-
thetized animals [by an overdose of ketamine (50 mg/ml),
xylazine (10 mg/ml), and atropine (0.1 mg/ml)]. Hippo-
campi were quickly dissected and homogenized using a
Dounce homogenizer (tight pestle) in ice-cold homogeni-
zation buffer consisting of 50 mM Tris/HCl (pH 7.4), 7.5%
glycerol, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
and complete protease inhibitor cocktail tablets (Roche
Diagnostics, Mannheim, Germany). After homogenization,
samples were centrifuged at 4,000 9 g for 20 min at 4C.
The resulting supernatants were centrifuged again until they
were clear. Protein concentration was measured using the
Bio-RadDCProteinassay(Bio-Rad Laboratories,Hercules,
CA, USA). Protein preparations were electrophoresed in
12.5% SDS gels under reducing conditions. Proteins were
subsequently transferred to nitrocellulose (Schleicher and
Schuell, Dassel, Germany) by semi-dry electroblotting for
2 h at 1 mA/cm
2 in transfer buffer containing 25 mM Tris
base, 150 mM glycine, and 10% (v/v) methanol. After
transfer, the blot was blocked with 5% (w/v) milk powder
and0.1%Tween-20inPBSfor1 hatroomtemperature,and
then incubated with monoclonal HCA2 (1:1000) or mono-
clonal HC10 (1:1000) antibodies or control mouse IgG
(Sigma) overnight at 4C. After washing three times for
5 min in PBS/0.1% Tween, the blot was incubated for 1 h at
room temperature with horseradish peroxidase coupled goat
anti-mouse IgG (1:4000, Santa Cruz Biotechnology, Santa
Cruz, CA, USA). Prior to visualization, the blot was washed
in PBS/0.1% Tween (3 9 5 min) and once more in PBS.
Signals were visualized by SuperSignal West Dura
enhanced luminescence substrate (Pierce Biotechnology,
Rockford, IL, USA).
Cell Culture and Immunoprecipitation
HEK293T cells were transfected with linearized, full-
length Caja-G carrying a C-terminal One-STrEP-tag in
pEXPR-IBA103 (IBA Technologies) using Fugene 6
(Roche, Indianapolis, IN, USA) as described by the man-
ufacturer. Stable clones were selected with Geniticine
(G418, Life Technologies, Karlsruhe, Germany) and
further propagated. Protein extracts were obtained as
described above. Puriﬁed Caja-G carrying a C-terminal
One-STrEP-tag was obtained following manufacturer’s
protocol (IBA Technologies). For immunoprecipitation,
1 mg/ml of protein extract was precleared with Protein G
Sepharose Fast Flow (GE Healthcare) for 1 h at 4C. Sam-
ples were centrifuged brieﬂy and supernatant was incubated
with either monoclonal HCA2 IgG (5 lg) or monoclonal
HC10 IgG (5 lg) or without antibodies overnight on rotary
platform at 4C, after which they were incubated with Pro-
tein G Sepharose Fast Flow (GE Healthcare) for 1 h at 4C.
Samples were then centrifuged and pellets were washed
three times with lysis buffer [50 mM Tris/HCl pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton-X 100 and com-
plete protease inhibitor cocktail tablet (Roche Diagnostics,
Mannheim, Germany)]. The bound proteins were eluted by
boiling in Laemmli buffer and western blot was performed
as described above. After transfer, the blot was blocked with
5% (w/v) BSA (Sigma) and 0.1% Tween-20 in PBS for 1 h
at room temperature, and then incubated with monoclonal
anti-STrEPHRP-conjugatedantibody(1:4000dilution,IBA
Technologies) overnight at 4C according to the manufac-
turer’s instructions. After washing three times for 5 min in
PBS/0.1% Tween and once more in PBS, signals were
visualized by SuperSignal West Pico enhanced lumines-
cence substrate (Pierce Biotechnology).
Electrophysiology
Animals were terminally anesthetized with an overdose of
ketamine (50 mg/ml), xylazine (10 mg/ml), and atropine
(0.1 mg/ml) and intracardially perfused with ice-cold oxy-
genated (95% O2 and 5% CO2) modiﬁed artiﬁcial
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123cerebrospinal ﬂuid (ACSF) containing (in mM): sucrose
220; KCl 1.9; Na2HPO4 1.25; glucose 10; NaHCO3 33;
MgCl2 26; CaCl2 20.5; kynurenic acid 2; and ascorbic acid
2 (all from Sigma). Transverse hippocampal slices (300–
400 lm) were prepared using a vibroslicer (752 M,
Campden Instruments, Loughborough, UK), transferred to
the recording chamber, and allowed to recover at 33C for
at least 90 min, after which they were kept at room tem-
perature. Recordings were performed on slices placed in a
submerged chamber perfused with oxygenated ACSF
(33C) containing (in mM): NaCl 124; KCl 5; Na2HPO4
1.25; glucose 10; NaHCO3 26; MgSO4 2; CaCl2 2; and
ascorbic acid 1 (all from Sigma). The recording chamber
was continuously perfused with ACSF and aerated with
95% O2 and 5% CO2 (2–3 ml/min). The temperature was
kept at 33C. CA3 neurons were visually identiﬁed using
infrared microscopy. The pipette solution contained (in
mM): potassium gluconate 135; MgCl2 2; CaCl2 0.1; EGTA
1; Na2 ATP 2; Na2 GTP 0.5; and HEPES 10. Spontaneous
glutamatergic excitatory postsynaptic currents (sEPSCs)
were recorded in the presence of 1 lM strychnine and 1 lM
bicuculline, as described by Medrihan et al. (2008). Either
control IgG or a mixture of HCA2 and HC10 antibodies at a
concentration of 1.5 mg/ml each were directly applied in
close proximity to neurons using glass pipettes (a schematic
representation of the recording chamber set-up is provided
in Supplementary ﬁgure 3). The tip size of the pipette,
pressure (0.5 mbar), and application time (0.5 s) were kept
constant in all experiments. In addition, the distance
between the pipette tip and the cells was monitored using a
camera with a liquid–crystal display device and was kept
constant in all experiments. Recordings of selected cells
were ﬁrst performed for 3 min without antibody application
(control recording); the antibodies were then applied for
20 min at 30 s intervals. Patches with a serial resistance of
[10 MXa, membrane resistance of\0.2 GX, or leak cur-
rents of[200 pA were excluded. The membrane currents
were ﬁltered by a four-pole Bessel ﬁlter at a corner fre-
quency of 2 kHz and digitized at a sampling rate of 5 kHz
using the DigiData 1322A interface (Molecular Devices,
Sunnyvale, CA, USA). Data acquisition and analysis were
done using commercially available software: pClamp 9.0
(Molecular Devices), MiniAnalysis (SynaptoSoft, Decatur,
GA, USA) and Prism 4 for Windows (GraphPad Software).
Results
MHCI Proteins Localize to Mossy Fibers in the
Common Marmoset Hippocampus
In our previous study, we observed high levels of MHCI
mRNA species throughout the hippocampus, particularly in
the dentate gyrus and in the CA3 area (Ro ¨lleke et al. 2006).
Speciﬁc antibodies against marmoset MHCI proteins are
not available; however, their high similarity with the
human homologs allowed us to use the well-characterized
HCA2 and HC10 antibodies against human MHCI proteins
for the detection of the marmoset MHCI proteins (Stam
et al. 1990). Western blot analysis revealed that both
antibodies recognized a band of approximately 45 kDa,
which is the expected molecular weight of the MHCI heavy
chain (Fig. 1a). Immunocytochemistry using the HCA2
antibody (Fig. 1b, f) exhibited a striking similarity with the
Fig. 1 MHCI protein is expressed in the mossy ﬁber pathway. a
HCA2 and HC10 antibodies recognized bands matching the reported
molecular weight of MHCI heavy chain (45 kDa) in western blots of
protein extracts from marmoset hippocampi (7-month-old animals).
Protein marker molecular weights are indicated in kDa. Halftone
photographs: Both antibodies against MHCI proteins, HC10 and
HCA2, gave similar staining patterns (b, c, f, g) with intense labeling
throughout the stratum lucidum (1-month-old animal). The staining
patterns obtained with these antibodies were very similar to the
Timm’s staining (D, H) which speciﬁcally labels the mossy ﬁber
pathway. Staining was identical in all ages examined; 1 day to 6 years
old animals were used. Control antibody revealed no staining (e).
Abbreviations: Ab antibody, CA3 Cornu ammonis 3, DG dentate
gyrus, H hilus. Scale bars for b–e: 1 mm. Scale bars for f–h:5 0lm
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mossy ﬁbers in the hippocampus (Fig. 1d, h; Henze et al.
2000). The strongest immunostaining was present in the
stratum lucidum (CA3; Fig. 1f). Staining with the HC10
antibody showed a similar pattern (Fig. 1c, g), however,
blood vessels were also stained with this antibody. There-
fore, we used the HCA2 antibody in further double-label-
ing experiments. It is important to note that no staining of
neuronal somata could be detected using these antibodies,
even after the epitope retrieval step. We detected an MHCI
signal solely within mossy ﬁbers in the hippocampal for-
mation. The distribution was identical in all ages examined
(1 day to 6 years old), with slightly varying intensity. Both
antibodies did not stain the CA1 and CA2 areas. Besides
the hippocampal mossy ﬁbers, MHCI could be detected in
nerve terminal regions throughout the brain, mainly within
hypothalamus and basal ganglia. MHCI was found to be
especially enriched in the reticular part of the substantia
nigra (Supplementary ﬁgure 1). No staining could be
detected in the cortex or in the cerebellum (data not
shown).
The anatomy of the primate hippocampus is well char-
acterized (Seress 2007) and a number of studies on MHCI
in mice have been performed in this brain region (Corri-
veau et al. 1998; Huh et al. 2000; Goddard et al. 2007).
Therefore, we decided to focus on MHCI in the hippo-
campal mossy ﬁbers in order to draw potential parallels
between different ﬁndings in this and other studies more
easily.
As previously mentioned, expression of MHCI on neu-
rons has always been a highly debated and controversial
topic. Thus, we ﬁrst compared the expression of MHCI in
the hippocampus with that of calbindin and GFAP. Cal-
bindin is a cytoplasmic protein strongly expressed in the
mossy ﬁbers (Sequier et al. 1990; Seress et al. 1993; Cooper
et al. 2008). MHCI and calbindin displayed very similar
staining pattern within the hippocampus (Fig. 2a, b). Both
are very likely present within the same structures in the
stratum lucidum, where the mossy ﬁbers form synapses
with CA3 pyramidal neurons (Fig. 2a–c). High magniﬁca-
tion revealed MHCI signals to be partially clustered at the
mossy ﬁbers, as previously reported in other systems (Fo-
oksman et al. 2006), and colocalizing with calbindin
(Fig. 2d, yellow structures and white arrowheads).
Glial ﬁbrillary acidic protein (GFAP) is a well estab-
lished marker of brain astrocytes (Eng et al. 2000). Double
labeling experiments revealed only occasional colocaliza-
tions of GFAP and MHCI signals (Fig. 2e–h). High mag-
niﬁcation images revealed MHCI signals dispersed
between GFAP-positive astrocyte processes (Fig. 2h, white
arrows).
To investigate the localization of MHCI in more detail,
we performed double-labeling experiments using antibod-
ies against Piccolo, a marker of the presynaptic active zone
Fig. 2 MHCI protein localizes to the mossy ﬁbers in the hippocam-
pus. MHCI signals (green, a) signiﬁcantly overlap with calbindin
signals (red, b, c), the marker of mossy ﬁbers. Almost no overlap is
detected between MHCI and the astrocyte marker GFAP (g). Higher
magniﬁcation reveals MHCI signals clustered over calbindin positive
nerve mossy ﬁbers (white arrowheads, d) and dispersed between
GFAP-positive astrocyte processes (white arrows, h). Animals
investigated were 5 months old. Abbreviations: lu stratum lucidum,
pyr stratum pyramidale
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123(Cases-Langhoff et al. 1996), and against postsynaptic
density protein of 95 kDa (PSD95), a marker of postsyn-
aptic densities (Kornau et al. 1995; Qin et al. 2001; Chang
et al. 2009). Piccolo is known to be situated along the
presynaptic membrane in the active zone region (Dondzillo
et al. 2010) and it displayed a distribution very similar to
MHCI in the hippocampus (Fig. 3a, b). Like MHCI, Pic-
colo was enriched in the stratum lucidum (Fig. 3b). PSD95
signal was present in both pyramidal layer and stratum
lucidum, as was previously reported (Fig. 3e; Qin et al.
2001). However, it was not as enriched as Piccolo and
MHCI within the mossy ﬁber terminals in stratum lucidum.
Quantiﬁcation of immunoﬂuorescence revealed that clus-
ters of MHCI signals overlapped mainly with Piccolo
signals, whereas very little overlap was detected with
PSD95 (Fig. 3i). High magniﬁcation images revealed sig-
niﬁcant colocalization of MHCI and Piccolo signals
(Fig. 3g; yellow spots and white arrowheads). Clusters of
MHCI and PSD95 signals were also found to partially
overlap (Fig. 3h, white arrowheads). This is not surprising
since PSD95, as a component of the postsynaptic densities
(Cho et al. 1992; Hunt et al. 1996), is located in direct
apposition to the presynaptic terminal membrane, and these
two structures cannot be clearly distinguished from each
other with standard confocal microscopy. This ﬁnding was
similar to what has been observed previously with synap-
sin-I and PSD95 in cerebellum (Castejon et al. 2004) and
colocalization of presynaptic proteins (such as synapsin-I)
Fig. 3 MHCI protein is localized on the presynaptic side of the
mossy ﬁber–CA3 synapse. MHCI signals (green, a) signiﬁcantly
overlap with those of Piccolo (red, b, c), marker of the presynaptic
active zone. Very little overlap is detected between MHCI (d) and the
postsynaptic marker PSD95 (e, f). Higher magniﬁcation reveals
MHCI signal clustered over Piccolo-positive regions (white arrow-
heads, g). Some PSD95 signals emerge close to MHCI signals (white
arrowheads, h). Quantiﬁcation of immunoﬂuorescence revealed that
MHCI is mainly associated with the presynaptic side of the mossy
ﬁber-CA3 synapses (i). Animals used were 7 months old. Data
represent means ± SEM, N = 3. Signiﬁcant differences between
groups as determined by Student’s t-test: ** P\0.01. Abbreviations:
lu stratum lucidum, pyr stratum pyramidale; * CA3 pyramidal neuron,
ICQ intensity correlation quotient
Cell Mol Neurobiol (2010) 30:827–839 833
123with PSD95 has previously been reported (Castejon et al.
2004; Graf et al. 2004; Cheng et al. 2008). These data
suggest that MHCI is mainly localized presynaptically, at
or very near the synapses themselves.
MHCI Proteins are Mainly Present in the Giant Mossy
Fiber Terminals
In the hippocampus, mossy ﬁbers form specialized ‘‘giant’’
terminals that innervate the apical dendrites of CA3 pyra-
midal neurons. Moreover, small terminals innervate the
interneurons present in the hilus and in the stratum lucidum
(Henze et al. 2000; Nicoll and Schmitz 2005). The vesic-
ular glutamate transporter 1 (VGlut1) mainly localizes to
large mossy ﬁber terminals (Bellocchio et al. 1998; Herzog
et al. 2001; Cooper et al. 2008). In contrast, the vesicular
glutamate transporter 2 (VGlut2) is present in small ter-
minals, which are VGlut1 negative and make contacts with
the inhibitory interneurons (Herzog et al. 2006). To further
characterize the localization of MHCI protein in mossy
ﬁbers, we assessed its colocalization with VGlut1 and
VGlut2. MHCI proteins predominantly colocalized with
VGlut1-immunopositive clusters and the two immunoﬂu-
orescent signals intensively overlapped (Fig. 4c, d). MHCI
signals were clustered over presumptive VGlut1-positive
mossy ﬁber terminals (mft, Fig. 4d). In accordance with
previous ﬁndings (Bellocchio et al. 1998; Herzog et al.
2006; Cooper et al. 2008), VGlut1 was found to be very
abundant in the stratum lucidum and sparse in the pyra-
midal cell layer, while VGlut2 signals appeared predomi-
nantly as immunopositive puncta within the pyramidal
layer with a very sparse distribution within stratum luci-
dum (Fig. 4f). Very little colocalization of MHCI with
VGlut2 signals was observed (Fig. 4h). Quantiﬁcation of
immunoﬂuorescence revealed a stronger correlation
between MHCI and VGlut1 than between MHCI and
VGlut2, which (together with image analysis) suggested
that the MHCI proteins are mainly localized to the large
mossy ﬁber terminals that innervate CA3 pyramidal neu-
rons (that are in general VGlut2 negative). Furthermore,
MHCI is mainly absent from VGAT-positive interneuron
terminals within the hippocampus (Supplementary ﬁg-
ure 3; Cooper et al. 2008), which additionally suggests its
localization to the giant mossy ﬁber terminals.
Neuronal MHCI Proteins are Involved in Excitatory
Transmission at Mossy Fiber–CA3 Synapses in the
Marmoset Hippocampus
To elucidate the potential functions of neuronal MHCI
proteins, we performed whole-cell patch-clamp recordings
of CA3 neurons in acute slices of the marmoset hippo-
campus. As the gene knockdown technology in nonhuman
primates is still in its early stages (Sasaki et al. 2009), we
decided to interfere with the cell-surface expression of
MHCI proteins via the application of HCA2 and HC10
antibodies. Although HC10 and HCA2 were raised against
denatured MHCI heavy chains, we speciﬁcally immuno-
precipitated a native marmoset MHCI molecule from cells
transfected with a tagged marmoset MHCI construct using
both antibodies (Fig. 5).
As we have localized MHCI proteins to the VGlut1-
positive mossy ﬁber terminals in the marmoset hippo-
campus, we investigated the changes in spontaneous
excitatory postsynaptic currents (sEPSCs) exclusively in
CA3 neurons. Application of HC10 and HCA2 antibodies
signiﬁcantly decreased the frequency of sEPSCs. The
normalized mean frequency of sEPSCs decreased by
28.75% (±10.28%), 5 min after the application of the
antibodies compared with the baseline level (100%).
Twenty minutes after antibody application, the normalized
mean frequency decreased by 39.23% (±9.27%) [Fig. 6a
(right panel), b]. In addition, application of these antibodies
also transiently increased the normalized amplitude of
sEPSCs by 22.4% (±10.62%) after 10 min (Fig. 6a, c).
Application of the control IgG had no signiﬁcant effect on
either the frequency or the amplitude of sEPSCs [Fig. 6a
(left panel), b, c]. These data suggest that MHCI proteins
have a speciﬁc function in maintenance and regulation of
basal neurotransmission at the primate mossy ﬁber–CA3
synapses.
Discussion
Expression of MHC class I molecules in neurons of the
CNS has been debated over the years. The dogma of the
immune privilege of the brain supports the notion that
neurons normally do not express MHCI proteins, and that
neuronal MHCI molecules can only be observed after
induction by cytokines (Neumann et al. 1995). However,
several recent studies performed in rodents provide
experimental evidence emphasizing an important role for
MHCI molecules in the modulation of synaptic plasticity
and in the proper development of brain circuitry in the
normal, noninjured brain (Corriveau et al. 1998; Huh et al.
2000; Goddard et al. 2007).
Although there are some differences in the structure and
function of molecules in the MHCI family between rodents
and primates, previous results reported by our group sug-
gested a relatively conserved expression pattern of a subset
of MHCI molecules in the brains of rodents and nonhuman
primates (Ro ¨lleke et al. 2006). MHCI molecules are very
numerous and are usually divided into classical and non-
classical MHCI molecules. Classical MHCI molecules are
in general associated with immune responses, while the
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123non-classical MHCIs have more elusive roles, especially
outside of the immune system (Arosa et al. 2007). In
rodents, classical MHCI genes have recently been impli-
cated in synaptic reﬁnement and the maintenance of syn-
aptic plasticity in cerebellum and visual system (Datwani
et al. 2009; McConnell et al. 2009). The non-classical
MHCI subset is believed to be involved in the proper
development of the vomeronasal organ in mice (Ishii and
Mombaerts 2008). We believe that the subset previously
detected by us in the marmoset brain belongs to the non-
classical MHCI molecules (Ro ¨lleke et al. 2006). In this
study, however, another subset of MHCI proteins displayed
Fig. 4 MHCI protein is present on large mossy ﬁber boutons. MHCI
(a) is predominantly localized on VGlut1 positive large mossy ﬁber
boutons (c, white arrowheads in d). Very little overlap is seen
between MHCI (e) and VGlut2 (f) which labels small mossy ﬁber
boutons and ﬁlopodial extensions (g, white arrowheads in h).
Quantiﬁcation of the immunoﬂuorescence revealed signiﬁcant differ-
ence between overlapping signals of MHCI with VGlut1 and VGlut2,
respectively (i). Animals used were 7 months old. Data represent
means ± SEM, N = 3. Signiﬁcant differences between groups as
determined by Student’s t-test: *** P\0.001. Abbreviations: lu
stratum lucidum, pyr stratum pyramidale, mft mossy ﬁber terminal, d
dendrite; * CA3 pyramidal neuron, ICQ intensity correlation quotient
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123distinct and so far unreported expression patterns and
properties.
Staining with antibodies that target the heavy-chain
subunit of the classical MHCI molecules revealed a strong
MHCI expression conﬁned to the mossy ﬁbers in the hip-
pocampal formation. Both antibodies used here targeted an
epitope situated in the most polymorphic region of the
MHCI molecules; therefore, these antibodies are speciﬁc
for only a small portion of MHCI proteins. In humans,
these antibodies recognize the classical MHCI molecules
and (in case of the HCA2 antibody) some non-classical
MHCI (Stam et al. 1986, 1990; Seitz et al. 1998; Gauster
et al. 2007). The marmoset MHCI genes are yet to be
characterized, but based on what has previously been
published on this topic (Cadavid et al. 1997) and on the
data available for the epitopes of these antibodies (Stam
et al. 1986, 1990; Seitz et al. 1998; Gauster et al. 2007), we
believe that the MHCI detected in this study belongs to the
classical subset. Both antibodies recognized bands of the
appropriate size on western blots and, with respect to the
Fig. 5 Antibodies HCA2 and HC10 recognize the native marmoset
MHCI protein. HEK293T cells were transfected with the marmoset
MHCI construct carrying One-STrEP-tag. Protein extracts were
immunoprecipitated with HCA2 and HC10 antibodies under
non-denaturing conditions and analyzed with Western blots using a
HRP-conjugated antibody against the STrEP-tag. Both antibodies
precipitated One-STrEP-tagged marmoset MHCI; mock (beads only)
revealed no signals. Puriﬁed marmoset MHCI with One-STrEP-tag
(Caja-G-STrEP) was used as a positive control. Lanes between mock,
immunoprecipitates and the puriﬁed Caja-G protein were kept empty
in order to avoid sample spillover and lane contamination. Protein
marker molecular weights are indicated in kDa
Fig. 6 Application of antibodies against MHC class I proteins to
marmoset hippocampal slices decreases frequency of sEPSCs. a
Representative recordings of pharmacologically isolated spontaneous
excitatory postsynaptic currents (sEPSC) from CA3 neurons during
the experiment. Recordings with the application of control immuno-
globulins are on the left side, and recordings with the application of
antibodies against MHCI proteins are on the right side. b Averaged
frequency of spontaneous ESPCs signiﬁcantly decreased after 10 min
of antibody application. Normalized mean frequency of sEPSCs
decreased 28.75% (±10.28) 5 minutes after the application of the
antibodies and continued to decrease down to 39.23% (±9.270) of
baseline level. c In addition, application of antibodies also transiently
increased the normalized amplitude of sEPSCs by 22.4% (±10.62)
compared to baseline level after 10 min. Application of control IgG
had no signiﬁcant effect on either the frequency or the amplitude of
sEPSCs. Animals used were 2–5 years old and no signiﬁcant
differences in both frequency and amplitude were observed with
regard to the age of animals. Data represent means ± SEM. Numbers
in parentheses indicate the number of neurons/marmosets tested for
each experimental group. Distribution of data was tested with
Kolmogorov–Smirnov test. Signiﬁcant differences between groups
as determined by One-way ANOVA with repeated measures with
Dunnet’s post hoc-test using initial recording without antibody
application as control: * P\0.05, ** P\0.01
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123neuronal staining, yielded almost identical staining patterns
in immunocytochemical experiments, which supports their
speciﬁcity. In addition, both HCA2 and HC10 immuno-
precipitated a native, classical marmoset MHCI protein,
Caja-G.
Our double-labeling experiments suggest that MHCI
proteins are localized on the nerve terminals, and not on
glial processes. Furthermore, our experiments suggest that
the MHCI proteins targeted here are presynaptic and pri-
marily associated with the large mossy ﬁber boutons,
which provide the main excitatory input to CA3 pyramidal
neurons. Thus, the present results from marmosets differ
from previous ﬁndings in mice, in which a postsynaptic
role of MHCI proteins was discussed (Goddard et al. 2007).
In accordance with the presynaptic localization detected
here, MHCI proteins have recently been reported in the
nerve terminals at the neuromuscular junction in mice
(Thams et al. 2009). The fact that no MHCI proteins were
detected in the hippocampal mossy ﬁbers of mice may be
due to a lack of suitable antibodies against mouse MHCI
proteins. However, it is also possible that MHCI expression
in mossy ﬁbers is a marmoset (or primate)-speciﬁc trait. As
previously mentioned, the non-classical MHCI molecules
exhibit expression patterns that are very similar to the one
detected in rodents (Corriveau et al. 1998;R o ¨lleke et al.
2006). Given the high evolution rate of MHCI molecules
(Kumanovics et al. 2003), it is likely that a fraction of
classical MHCI proteins developed a new function and
localization. A detailed comparative study between rodents
and primates using equivalent tools is needed to elucidate
this issue. However, the results obtained using whole-cell
patch-clamp recordings in marmoset CA3 neurons suggest
the presence of interspecies differences.
Electrophysiology in nonhuman primates is not com-
monly employed given that mouse models are usually
readily available. Furthermore, ethical standards regarding
the use of nonhuman primates in neurobiological research
limit the number of primates as experimental animals, and
the preparation of acute brain slices from primates is more
arduous compared to the preparation of rodent acute brain
slices. However, the opposing results with respect to the
localization of MHCI molecules in the hippocampus of
mice and marmosets did not allow us to use mice for
electrophysiological experiments. In addition, we felt it
was important to elucidate the function of neuronal MHCI
in the primate hippocampus precisely because of the pro-
nounced interspecies differences in their localization
within the hippocampal formation. As MHCI knockout
marmosets or speciﬁc neuronal MHCI antagonists are not
currently available, we used antibodies to block MHCI on
the surface of mossy ﬁber terminals. The effects observed
were not an artifact of the antibody application, as there
was no signiﬁcant effect of the application of control
immunoglobulins in the same concentration (Fig. 6). Pre-
viously published data suggest that the use of antibodies
that block cell-surface receptors is an adequate method for
investigating the function of proteins for which knockout
models or antagonists are not available (Buﬂer et al. 1996;
Saghatelyan et al. 2000; Mameli et al. 2005).
In our experiments, the normalized mean frequency of
sEPSCs was signiﬁcantly reduced after application of the
blocking antibodies and this effect increased proportionally
with the duration of the incubation. Furthermore, we
observed a small, but signiﬁcant transient increase in the
amplitude of sEPSCs (Fig. 6). These results did not match
previous observations in rodents where it has been found
that the lack of surface MHCI expression leads to an
increase in mEPSCs (miniature EPSCs) frequency of hip-
pocampal neurons (Goddard et al. 2007). As already
mentioned, it is possible that the MHCI molecules targeted
in the present study belong to a subset of MHCIs that has
not yet been detected in mice because of the unavailability
of proper antibodies. However, the mice used in the pre-
vious studies lacked expression of the majority of, if not
all, MHCI genes (Goddard et al. 2007). On the other hand,
we recorded sEPSCs here, not mEPSCs (as in the study in
mice), which may also account for some of the differences
observed.
It is obvious that evolution provided MHCI molecules
with a number of diverse functions, both immune and
nonimmune (Fishman et al. 2004). A potential explanation
for the function of MHCI at the mossy ﬁber–CA3 synapses
arises when previous studies on MHCI are taken into
consideration. The mossy ﬁber–CA3 synapse displays a
number of peculiarities when compared with the majority
of CNS synapses. For instance, it is characterized by a low
basal neurotransmission, which is maintained via the acti-
vation of receptors that have inhibitory effects on synaptic
transmission (Nicoll and Schmitz 2005). Given that the
best characterized nonimmune function of MHCI mole-
cules is the regulation of trafﬁcking and internalization of
various receptors (Arosa et al. 2007), we hypothesize that
the function of neuronal MHCI proteins (consistent with
the results obtained here) is the proper internalization of
one or several of those receptors. One may speculate that
blocking the interaction of MHCI molecules with their
receptors by application of anti-MHCI antibodies would
prolong inhibitory signaling, thus reducing the frequency
of sEPSCs. This does not fully explain the transient
increase in the amplitude of sEPSCs: although changes in
the amplitude of the spontaneous currents usually imply a
defect in the postsynapse, sometimes they may also be a
reﬂection of a presynaptic mechanism (Sharma and Vii-
jayaraghavan 2003). Further electrophysiological analyses
are required to dissect the action of MHCI proteins in
synaptic transmission. The identiﬁcation of interacting
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123partner(s) and signaling mechanisms are crucial to the
elucidation of the function of neuronal MHCI molecules.
In conclusion, the present study contributes to the
growing body of evidence that MHCI molecules are
involved in synaptic plasticity processes in the CNS. It
remains unclear whether the presynaptic and mossy ﬁber-
speciﬁc expression of MHCI molecules observed in this
study is marmoset speciﬁc, or whether it is a characteristic
of all nonhuman primates. A number of proteins display
differential localization in rodents and primates, which is
usually taken as a possible basis for the evolution of the
primate brain with respect to cognitive functions. Fur-
thermore, a concept of MHCI signaling in neurons has very
important implications, particularly when considering
autoimmune diseases that affect the CNS and various dis-
eases genetically linked to the MHC, such as autism
(Belmonte et al. 2004). With this in mind, further research
is required to elucidate the exact mechanisms of the action
of nonhuman primate neuronal MHCI, particularly
regarding interspecies expression differences.
Acknowledgments The authors wish to thank T. Meyer-Burhenne
and S. Leineweber for expert animal care, A. Hoffmann, J. Krenzek,
S. Kosin, A. Heutz, and A. Zank for technical assistance, Dr. B. Cze ´h
for assistance with the Timm’s staining protocol, Dr. L. Medrihan for
help establishing the patch clamp recording techniques and Dr. B.
Cooper for invaluable advice regarding synaptic markers. AR was
supported by an EC fellowship for Neuroscience Early Stage
Research Training (NEUREST) and was a student of the MSc/PhD
Molecular Biology Graduate Program in Go ¨ttingen, Germany. This
work was supported by EU grant NEST-28594 and the SFB 449, TP
B6.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
Aarli JA (1983) The immune system and the nervous system. J Neurol
229:137–154
Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with
ImageJ. Biophotonics Int 11:36–42
Arosa FA, Santos SG, Powis SJ (2007) Open conformers: the hidden
face of MHC-I molecules. Trends Immunol 28:115–123
Bellocchio EE, Hu H, Pohorilee A, Chan J, Pickerl VM, Edwards RH
(1998) The localization of the brain speciﬁc inorganic phosphate
transporter suggests a speciﬁc presynaptic role in glutamatergic
transmission. J Neurosci 18:8848–8849
Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper
RA, Webb SJ (2004) Autism and abnormal development of brain
connectivity. J Neurosci 24:9228–9231
Buﬂer J, Kahlert S, Tzartos S, Toyka KV, Maelicke A, Franke C
(1996) Activation and blockade of mouse muscle nicotinic
channels by antibodies directed against the binding site of the
acetylcholine receptor. J Physiol 492:107–114
Cadavid LF, Shufﬂebotham C, Ruiz FJ, Yeager M, Hughes AL,
Watkins DI (1997) Evolutionary instability of the major
histocompatibility complex class I loci in New World primates.
Proc Natl Acad Sci USA 94:14536–14541
Cases-Langhoff C, Voss B, Garner AM, Appeltauer U, Takei K,
Kindler S, Veh RW, De Camilli P, Gundelﬁnger ED, Garner CC
(1996) Piccolo, a novel 420 kDa protein associated with the
presynaptic cytomatrix. Eur J Cell Biol 69:214–223
Castejon OJ, Fuller L, Dailey ME (2004) Localization of synapsin-I
and PSD-95 in developing postnatal rat cerebellar cortex. Brain
Res Dev Brain Res 151:25–32
Chang LR, Liu JP, Zhang N, Wang YJ, Gao XL, Wu Y (2009)
Different expression of NR2B and PSD-95 in rat hippocampal
subregions during postnatal development. Microsc Res Tech
72:517–524
Cheng C, Gao S, Zhao J, Niu S, Chen M, Li X, Qin J, Shi S, Guo Z,
Shen A (2008) Spatiotemporal patterns of postsynaptic density
(PSD)-95 expression after rat spinal cord injury. Neuropathol
Appl Neurobiol 34:340–356
Cho K-O, Hunt CA, Kennedy MB (1992) The rat brain postsynaptic
density fraction contains a homolog of the Drosophila disc-large
tumor suppressor protein. Neuron 9:929–942
Cooper B, Werner HB, Flu ¨gge G (2008) Glycoprotein M6a is present
in glutamatergic axons in adult rat forebrain and cerebellum.
Brain Res 1197:1–12
Corriveau RA, Huh GS, Shatz CJ (1998) Regulation of class I MHC
gene expression in the developing and mature CNS by neural
activity. Neuron 21:505–520
Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA
(2005) Mechanisms of MHC class I-restricted antigen processing
and cross-presentation. Immunol Rev 207:145–157
Datwani A, McConnell MJ, Kanold PO, Micheva KD, Busse B,
Shamloo M, Smith SJ, Shatz CJ (2009) Classical MHCI
molecules regulate retinogeniculate reﬁnement and limit ocular
dominance plasticity. Neuron 64:463–470
Dondzillo A, Sa ¨tzler K, Horstmann H, Altrock WD, Gundelﬁnger ED,
Kuner T (2010) Targeted three-dimensional immunohistochem-
istry reveals localization of presynaptic proteins Bassoon and
Piccolo in the rat calyx of Held before and after the onset of
hearing. J Comp Neurol 518:1008–1029
Eng LF, Ghirnikar RS, Lee YL (2000) Glial ﬁbrillary acidic protein:
GFAP-thirty-one years (1969–2000). Neurochem Res 25:1439–
1451
Fishman D, Elhyany S, Segal S (2004) Non-immune functions of
MHC class I glycoproteins in normal and malignant cells. Folia
Biol 50:35–42
Fooksman DR, Gronvall GK, Tang Q, Edidin M (2006) Clustering
class I MHC modulates sensitivity of T cell recognition. J
Immunol 176:6673–6680
Gauster M, Blaschitz A, Dohr G (2007) Monoclonal antibody HC10
does not bind HLA-G. Rheumatology 46:892–893
Goddard CA, Butts DA, Shatz CJ (2007) Regulation of CNS synapses
by neuronal MHC class I. Proc Natl Acad Sci USA 104:6828–
6833
Graf ER, Zhang XZ, Jin S-X, Linhoff MW, Craig AM (2004)
Neurexins induce differentiation of GABA and glutamate
postsynaptic specializations via neuroligins. Cell 119:1013–1026
Henze DA, Urban NN, Barrionuevo G (2000) The multifarious
hippocampal mossy ﬁber pathway: a review. Neuroscience
98:407–427
Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C,
Gasnier B, Giros B, ElMestikawy S (2001) The existence of a
second vesicular glutamate transporter speciﬁes subpopulations
of glutamatergic neurons. J Neurosci 21:RC181:1–6
Herzog E, Takamori S, Jahn R, Brose N, Wojcik SM (2006) Synaptic
and vesicular colocalization of the glutamate transporters
838 Cell Mol Neurobiol (2010) 30:827–839
123VGLUT1 and VGLUT2 in the mouse hippocampus. J Neuro-
chem 993:1011–1018
Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ
(2000) Functional requirement for class I MHC in CNS
development and plasticity. Science 290:2155–2159
Hunt CA, Schenker LJ, Kennedy MB (1996) PSD-95 is associated
with the postsynaptic density and not with the presynaptic
membrane at forebrain synapses. J Neurosci 16:1380–1388
Ishii T, Mombaerts P (2008) Expression of nonclassical class I major
histocompatibility genes deﬁnes a tripartite organization of the
mouse vomeronasal system. J Neurosci 28:2332–2341
Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995) Domain
interaction between NMDA receptor subunits and the postsyn-
aptic density protein PSD-95. Science 269:1737–1740
Kumanovics A, Takada T, Lindahl KF (2003) Genomic organization
of the mammalian MHC. Annu Rev Immunol 21:629–657
Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF (2004) A
syntaxin 1, Galpha(o), and N-type calcium channel complex at a
presynaptic nerve terminal: analysis by quantitative immuno-
colocalization. J Neurosci 24:4070–4081
Mameli M, Carta M, Partridge LD, Valenzuela CF (2005) Neuros-
teroid-induced plasticity of immature synapses via retrograde
modulation of presynaptic NMDA receptors. J Neurosci 25:
2285–2294
McConnell MJ, Huang YH, Datwani A, Shatz CJ (2009) H2-K(b) and
H2-D(b) regulate cerebellar long-term depression and limit
motor learning. Proc Natl Acad Sci USA 106:6784–6789
Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I,
Missler M, Zhang W (2008) Early defects of GABAergic
synapses in the brain stem of a MeCP2 mouse model of Rett
syndrome. J Neurophysiol 99:112–121
Neumann H, Cavalie A, Jenne DE, Wekerle H (1995) Induction of
MHC class I genes in neurons. Science 269:549–552
Nicoll RA, Schmitz D (2005) Synaptic plasticity at hippocampal
mossy ﬁbre synapses. Nat Rev Neurosci 6:863–876
Qin L, Marrs GS, McKim R, Dailey ME (2001) Hippocampal mossy
ﬁbers induce assembly and clustering of PSD95-containing
postsynaptic densities independent of glutamate receptor activa-
tion. J Comp Neurol 440:284–298
Ro ¨lleke U, Flu ¨gge G, Plehm S, Schlumbohm C, Armstrong VW,
Dressel R, Uchanska-Ziegler B, Ziegler A, Fuchs E, Czeh B,
Walter L (2006) Differential expression of major histocompat-
ibility complex class I molecules in the brain of a New World
monkey, the common marmoset (Callithrix jacchus). J Neuro-
immunol 176:39–50
Saghatelyan AK, Gorissen S, Albert M, Hertlein B, Schachner M,
Dityatev A (2000) The extracellular matrix molecule tenascin-R
and its HNK-1 carbohydrate modulate perisomatic inhibition and
long-term potentiation in the CA1 region of the hippocampus.
Eur J Neurosci 12:3331–3342
Sasaki E, Suemizu H, Shimada A, Hanazawa K, Oiwa R, Kamioka M,
Tomioka I, Sotomaru Y, Hirakawa R, Eto T, Shiozawa S, Maeda
T, Ito M, Ito R, Kito C, Yagihashi C, Kawai K, Miyoshi H,
Tanioka Y, Tamaoki N, Habu S, Okano H, Nomura T (2009)
Generation of transgenic non-human primates with germline
transmission. Nature 459:523–527
Seitz C, Uchanska-Ziegler B, Zank A, Ziegler A (1998) The
monoclonal antibody HCA2 recognises a broadly shared epitope
on selected classical as well as several non-classical HLA class I
molecules. Mol Immunol 35:819–827
Sequier JM, Hunziker W, Andressen C, Celio MR (1990) Calbindin
D-28 k protein and mRNA localization in the rat brain. Eur J
Neurosci 2:1118–1126
Seress L (2007) Comparative anatomy of the hippocampal dentate
gyrus in adult and developing rodents, non-human primates and
humans. Prog Brain Res 163:23–41
Seress L, Gulyas AI, Ferrer I, Tunon T, Soriano E, Freund TF (1993)
Distribution, morphological features, and synaptic connections
of parvalbumin- and calbindin D28k-immunoreactive neurons in
the human hippocampal formation. J Comp Neurol 337:208–230
Seress L, Abraham H, Paleszter M, Gallyas F (2001) Granule cells are
the main source of excitatory input to a subpopulation of
GABAergic hippocampal neurons as revealed by electron
microscopic double staining for zinc histochemistry and parval-
bumin immunocytochemistry. Exp Brain Res 136:456–462
Sharma G, Viijayaraghavan S (2003) Modulation of presynaptic store
calcium induces release of glutamate and postsynaptic ﬁring.
Neuron 38:929–939
Solheim JC (1999) Class I MHC molecules: assembly and antigen
presentation. Immunol Rev 172:11–19
Stam NJ, Spits H, Ploegh HL (1986) Monoclonal antibodies raised
against denatured HLA-B locus heavy chains permit biochemical
characterization of certain HLA-C locus products. J Immunol
137:2299–2306
Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL (1990)
HLA-A- and HLA-B-speciﬁc monoclonal antibodies reactive
with free heavy chains in western blots, in formalin-ﬁxed,
parafﬁn-embedded tissue sections and in cryo-immuno-electron
microscopy. Int Immunol 2:113–125
Thams S, Brodin P, Plantman S, Saxelin R, Karre K, Cullheim S
(2009) Classical major histocompatibility complex class I
molecules in motoneurons: new actors at the neuromuscular
junction. J Neurosci 29:13503–13515
Cell Mol Neurobiol (2010) 30:827–839 839
123